Current concepts on coronary revascularization using BRS in patients with diabetes and small vessels disease.

about

Current concepts on coronary revascularization using BRS in patients with diabetes and small vessels disease.

Item

http://www.wikidata.org/entity/Q47999843

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Current concepts on coronary r ...... tes and small vessels disease.

@en

Current concepts on coronary r ...... tes and small vessels disease.

@nl

type

Item

label

Current concepts on coronary r ...... tes and small vessels disease.

@en

Current concepts on coronary r ...... tes and small vessels disease.

@nl

prefLabel

Current concepts on coronary r ...... tes and small vessels disease.

@en

Current concepts on coronary r ...... tes and small vessels disease.

@nl

P1476

Current concepts on coronary r ...... tes and small vessels disease.

@en

P2093

Daisuke Ueshima

http://www.w3.org/2001/XMLSchema#string

Giulia Masiero

http://www.w3.org/2001/XMLSchema#string

Giuseppe Tarantini

http://www.w3.org/2001/XMLSchema#string

Marco Mojoli

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (

Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes

Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis

Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial.

Percutaneous coronary intervention for small vessel coronary artery disease.

Restenosis: delineating the numerous causes of drug-eluting stent restenosis.

Clinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413).

The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled.

P304

S940-S949

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/JTD.2017.06.36

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 9

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28894600

http://www.w3.org/2001/XMLSchema#string

P921

revascularization

P932

5583088

http://www.w3.org/2001/XMLSchema#string